LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EARNINGS FLASH L impact Sep 30, 2026, 12:50 PM UTC

Recon Technology reports fiscal 2026 results

Recon Technology, Ltd reported financial year results for fiscal 2026.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

RCON

Related stories

Tower revises FY26 outlook, shares hit near one-month peak New Zealand insurer Tower shares rose as much as 2% to NZ$2.030, their highest level since September 10, after the company revised its FY26 underlying net profit after tax forecast M impact | EARNINGS | Oct 05, 2026, 10:00 PM UTC Live Cattle futures test channel lows as fourth quarter begins. Virginia McGathey analyzes the latest action in the livestock market as the fourth quarter gets underway. Live Cattle futures face pressure amid weaker trader confidence, testing t L impact | EARNINGS | Oct 05, 2026, 10:00 PM UTC DayOne Data Centers Files For US IPO, Seeks Nasdaq Listing Under “DODC” H1 2026 Revenue Rose 238% YoY To $512M; 2025 Revenue Was $484.3M L impact | EARNINGS | Oct 05, 2026, 08:31 PM UTC NeoGenomics Reports 3Q Revenue of About $209M NeoGenomics reported its third-quarter revenue to be approximately $209 million. M impact | EARNINGS | Oct 05, 2026, 08:15 PM UTC US Stocks Gain as Big Tech Shares Rally US stock indices closed higher on Monday as a rally in heavyweight technology shares outweighed concerns over still-elevated oil prices and bond yields. The S&P 500 rose 0.7%, the H impact | EARNINGS | Oct 05, 2026, 08:13 PM UTC AbbVie cuts Q3 EPS forecast to $3.73-$3.77 on $216 mln expense AbbVie cut its Q3 adjusted diluted EPS guidance to USD 3.73-3.77 from USD 3.84-3.88, citing acquired IPR&D and milestones expense of USD 216 million, equal to a USD 0.11 per-share M impact | EARNINGS | Oct 05, 2026, 08:11 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.